Bone of Contention: The Unlikely Switch in Osteoporosis Treatment Osteoporosis has long been a silent partner in the decline of physical vigor, its effects often masked by more visible signs of aging.
A recent breakthrough at Leipzig University offers hope for those who've lost their footing to this condition.
Researchers have identified an experimental compound called AP503 that activates GPR133, a receptor responsible not only for strengthening bones but also building muscle mass – a combination that could revolutionize age related decline.